Stocktoria
PRF Technologies Ltd. PRFX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-09-01
PRF Technologies Ltd. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -30129.4% | — | — | — | — |
| Net margin | -29541.2% | — | — | — | — |
| FCF margin | -23276.5% | — | — | — | — |
| Return on assets | -41.9% | -322.4% | -94.1% | -71.3% | -38.0% |
| Return on equity | -54.1% | -799.8% | -129.1% | -79.8% | -40.1% |
| Current ratio | 1.78 | 1.81 | 4.07 | 11.55 | 25.13 |
Source: SEC EDGAR filings · CIK 0001801834 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.